Advanced in Movement Disorders

Clement T. Loy

Sydney, NSW, AU 
Advanced in Movement Disorders
Sydney, NSW, AU 
OverviewLocationsClinical Research

Overview

Clement Loy practices in Sydney, Australia. Mr. Loy is rated as an Advanced expert by MediFind in the treatment of Movement Disorders. His top areas of expertise are Huntington Disease, Chorea, Dementia, and Movement Disorders.

His clinical research consists of co-authoring 56 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 24 articles and participated in 4 clinical trials in the study of Movement Disorders.

Gender
Male

Locations

Sydney, NSW, Australia
Other Locations
Westmead, NSW, Australia
Camperdown, NSW, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Multicenter, Randomized, Double-blind, Placebo Controlled, Phase 1b/2a Study of WVE-003 Administered Intrathecally in Patients With Huntington's Disease (SELECT-HD)
A Multicenter, Randomized, Double-blind, Placebo Controlled, Phase 1b/2a Study of WVE-003 Administered Intrathecally in Patients With Huntington's Disease (SELECT-HD)
Enrollment Status: Completed
Publish Date: August 12, 2025
Intervention Type: Drug
Study Drug: WVE-003
Study Phase: Phase 1/Phase 2
A Phase 2A, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington's Disease
A Phase 2A, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington's Disease
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients With Huntington's Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients With Huntington's Disease
Enrollment Status: Terminated
Publish Date: April 25, 2022
Intervention Type: Drug
Study Drug: WVE-120102
Study Phase: Phase 1/Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients With Huntington's Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients With Huntington's Disease
Enrollment Status: Terminated
Publish Date: February 10, 2022
Intervention Type: Drug
Study Drug: WVE-120101
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

56 Total Publications

Effective housing and support models for people with Huntington's disease: A scoping review.
Effective housing and support models for people with Huntington's disease: A scoping review.
Journal: Journal of Huntington's disease
Published: October 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Loy's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile